Published in Health Econ on April 01, 1992
The efficacy of automated "disease/no disease" grading for diabetic retinopathy in a systematic screening programme. Br J Ophthalmol (2007) 2.59
Cost effectiveness analysis of screening for sight threatening diabetic eye disease. BMJ (2000) 1.92
Mammography screening: an incremental cost effectiveness analysis of double versus single reading of mammograms. BMJ (1996) 1.70
Barriers to and facilitators of compliance with clinic-based cervical cancer screening: population-based cohort study of women aged 23-60 years. PLoS One (2015) 1.40
The impact of the Health Technology Board for Scotland's grading model on referrals to ophthalmology services. Br J Ophthalmol (2005) 1.08
Impact of diabetic retinopathy screening on a British district population: case detection and blindness prevention in an evidence-based model. J Epidemiol Community Health (1998) 0.95
Patient costs in anticoagulation management: a comparison of primary and secondary care. Br J Gen Pract (2001) 0.84
Cost-effectiveness of Different Diabetic Retinopathy Screening Modalities. J Diabetes Sci Technol (2015) 0.79
Contact frequency, travel time, and travel costs for patients with rheumatoid arthritis. Int J Rheumatol (2014) 0.78
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet (1992) 11.50
The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet (2002) 10.52
Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess (1998) 9.32
Laparoscopic versus open inguinal hernia repair: randomised prospective trial. Lancet (1994) 6.91
Reliability of league tables of in vitro fertilisation clinics: retrospective analysis of live birth rates. BMJ (1998) 5.96
Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol (1994) 5.02
Cost-benefit analysis of long-term haemodialysis for chronic renal failure. Br Med J (1975) 3.87
Bayesian approaches to random-effects meta-analysis: a comparative study. Stat Med (1995) 3.71
Modelling in economic evaluation: an unavoidable fact of life. Health Econ (1997) 3.40
Variations in GP night visiting rates: medical organisation and consumer demand. Br Med J (1977) 3.24
Diabetes prevalence in England, 2001--estimates from an epidemiological model. Diabet Med (2006) 2.92
Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales. Stat Med (2002) 2.86
Screening for treatable diabetic retinopathy: a comparison of different methods. Diabet Med (1991) 2.76
Conservative treatment of mild/moderate cervical dyskaryosis: long-term outcome. Lancet (1992) 2.64
Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial. Lancet (2004) 2.63
Final follow-up of the Multicentre Aneurysm Screening Study (MASS) randomized trial of abdominal aortic aneurysm screening. Br J Surg (2012) 2.55
Monitoring of large randomised clinical trials: a new approach with Bayesian methods. Lancet (2001) 2.35
Mapping the densities of malaria vectors within a single village. Acta Trop (1995) 2.31
Statistical methodology for evaluating gastrointestinal symptoms. Clin Gastroenterol (1985) 2.29
The episode-free day as a composite measure of effectiveness: an illustrative economic evaluation of formoterol versus salbutamol in asthma therapy. Pharmacoeconomics (1993) 2.26
Probabilistic prediction in patient management and clinical trials. Stat Med (1987) 2.10
Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Br Heart J (1995) 2.09
Outcome in neonates with Ebstein's anomaly. J Am Coll Cardiol (1992) 1.99
Issues in data monitoring and interim analysis of trials. Health Technol Assess (2005) 1.96
Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina. Lancet (1998) 1.94
Estimating the true extent of cognitive decline in the old old. J Am Geriatr Soc (1999) 1.90
The CHART trials: Bayesian design and monitoring in practice. CHART Steering Committee. Stat Med (1994) 1.90
Flexible random-effects models using Bayesian semi-parametric models: applications to institutional comparisons. Stat Med (2007) 1.90
Off-the-shelf proteins that rival tailor-made antibodies as catalysts. Nature (1996) 1.84
A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion. Stat Med (1986) 1.82
Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study. BMJ (2007) 1.81
Comparison of Bayesian with group sequential methods for monitoring clinical trials. Control Clin Trials (1989) 1.79
Health service costs of coronary angioplasty and coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial. Lancet (1994) 1.78
Observer variation and discriminatory value of biopsy features in inflammatory bowel disease. Gut (1994) 1.64
A relative cost-effectiveness analysis of different methods of screening for diabetic retinopathy. Diabet Med (1991) 1.55
Radiology report times: impact of picture archiving and communication systems. AJR Am J Roentgenol (1998) 1.55
Risk stratification for open heart surgery. BMJ (1992) 1.51
The benefits of hospital-wide picture archiving and communication systems: a survey of clinical users of radiology services. Br J Radiol (1999) 1.47
Distribution of hospital provision: policy themes and resource variations. Br Med J (1975) 1.42
A database on dyspepsia. Gut (1994) 1.41
Assessing the costs of healthcare technologies in clinical trials. Health Technol Assess (1999) 1.39
Application of Bayesian statistics to decision making during a clinical trial. Stat Med (1992) 1.35
Use of risk-adjusted CUSUM and RSPRT charts for monitoring in medical contexts. Stat Methods Med Res (2003) 1.35
Population characteristics and the distribution of general medical practitioners. Br Med J (1979) 1.28
Measuring the effectiveness of heart transplant programmes: quality of life data and their relationship to survival analysis. J Chronic Dis (1987) 1.27
Management of women with a cervical smear showing a mild degree of dyskaryosis: a review of policy. Cytopathology (1992) 1.27
Computer aided decision making in medicine. Br Med J (Clin Res Ed) (1984) 1.24
Effects of an ambient air pollution intervention and environmental tobacco smoke on children's respiratory health in Hong Kong. Int J Epidemiol (1996) 1.23
Dietary micronutrient intake and risk of progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men. Am J Epidemiol (1993) 1.23
Long-term survivors with HIV-1 infection: incubation period and longitudinal patterns of CD4+ lymphocytes. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.22
Approximate cross-validatory predictive checks in disease mapping models. Stat Med (2003) 1.22
Setting the minimal metrically detectable change on disability rating scales. Arch Phys Med Rehabil (1997) 1.19
Cytomegalovirus infection in cardiac transplant recipients associated with chronic T cell subset ratio inversion with expansion of a Leu-7+ TS-C+ subset. Clin Exp Immunol (1985) 1.18
Survival analysis in observational studies. Stat Med (1997) 1.17
The what, why and how of Bayesian clinical trials monitoring. Stat Med (1994) 1.16
Estimation of population pharmacokinetics using the Gibbs sampler. J Pharmacokinet Biopharm (1995) 1.14
How cost-effective is screening for abdominal aortic aneurysms? J Med Screen (2007) 1.14
Monitoring clinical trials: conditional or predictive power? Control Clin Trials (1986) 1.14
An analysis of repeated biopsies following cardiac transplantation. Stat Med (1984) 1.14
The time trade-off technique: how do the valuations of breast cancer patients compare to those of other groups? Qual Life Res (1994) 1.14
Modelling the long-term cost-effectiveness of endovascular or open repair for abdominal aortic aneurysm. Br J Surg (2008) 1.13
Using routine intelligence to target inspection of healthcare providers in England. Qual Saf Health Care (2009) 1.12
Resource allocation for chronic stable angina: a systematic review of effectiveness, costs and cost-effectiveness of alternative interventions. Health Technol Assess (1998) 1.12
Evaluation of a diagnostic algorithm for heart disease in neonates. BMJ (1991) 1.11
Domiciliary thrombolysis by general practitioners. BMJ (1992) 1.11
On the magnitude and specificity of medium effects in enzyme-like catalysts for proton transfer. J Org Chem (2001) 1.11
Breast cancer in thyroid disease: fact or fallacy? Lancet (1981) 1.08
Comparison between two districts of the effects of an air pollution intervention on bronchial responsiveness in primary school children in Hong Kong. J Epidemiol Community Health (1998) 1.02
How does computer-aided diagnosis improve the management of acute abdominal pain? Ann R Coll Surg Engl (1992) 1.02
Evaluation of clinical decision-aids, with an application to a system for dyspepsia. Stat Med (1984) 1.02
Systematic review and meta-analysis of the growth and rupture rates of small abdominal aortic aneurysms: implications for surveillance intervals and their cost-effectiveness. Health Technol Assess (2013) 1.01
Changing patterns of coeliac disease frequency: an analysis of Coeliac Society membership records. Gut (1985) 1.00
Estimating pKa values for pentaoxyphosphoranes. J Am Chem Soc (2002) 0.99
Identifying the impact of diabetes research. Diabet Med (2006) 0.97
Taking a calculated risk: predictive scoring systems in dyspepsia. Scand J Gastroenterol Suppl (1987) 0.95
Dopaminergic effects on electrophysiological and functional MRI measures of human cortical stimulus-response power laws. Neuroimage (2004) 0.94
A unified method for monitoring and analysing controlled trials. Stat Med (1994) 0.93
Cardiac surgery for patients aged 65 years and older: a long term survival analysis. Br Heart J (1988) 0.93
Health-related quality of life following liver transplantation. Qual Life Res (1998) 0.92
Examining the influence of picture archiving communication systems and other factors upon the length of stay for patients with total hip and total knee replacements. Int J Technol Assess Health Care (1999) 0.91
A UK trial-based cost--utility analysis of transmyocardial laser revascularization compared to continued medical therapy for treatment of refractory angina pectoris. Eur J Cardiothorac Surg (2001) 0.91
Two types of trichromatic squirrel monkey share a pigment in the red-green spectral region. Vision Res (1985) 0.91
Rational approaches to the design of cationic gemini surfactants for gene delivery. J Am Chem Soc (2001) 0.90
The logical description of a disease class as a Boolean function with special reference to the irritable bowel syndrome. Clin Sci (Lond) (1984) 0.89
Surgical treatment of aortic coarctation in infants younger than three months: 1985 to 1990. Success of extended end-to-end arch aortoplasty. J Thorac Cardiovasc Surg (1994) 0.89
Intracortically distributed neurovascular coupling relationships within and between human somatosensory cortices. Cereb Cortex (2006) 0.88
Double-inlet ventricle presenting in infancy. I. Survival without definitive repair. J Thorac Cardiovasc Surg (1991) 0.87
The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial. Heart (2007) 0.86
Development of motor innervation of the chick following dorsal-ventral limb bud rotations. J Neurosci (1983) 0.86
How to interpret your dot: decoding the message of clinical performance indicators. J Perinatol (2008) 0.86
The lysozyme mechanism sorted -- after 50 years. Nat Struct Biol (2001) 0.86
Vesicles accelerate proton transfer from carbon up to 850-fold. Org Lett (2000) 0.85